HIV/AIDS
Reports from University of California, U.S., advance knowledge in HIV/AIDS research
Published in AIDS Weekly, January 15th, 2007
Study 1: Recently published research from the United States has documented the inhibition of HIV-1 integrase (IN) activity by synthetic peptides derived from the HIV-1HXB2 Pol region of the viral genome.
"Peptides deriving from the HIV-1 HXB2 Pol gene sequence were evaluated for inhibitory activity against wild-type (WT) and mutant HIV-1 IN," wrote Z. Zawahir and colleagues, University of California.
"The most potent peptide corresponding to a region on the reverse transcriptase (RT) subunit of the Pol polyprotein showed IC50 value of 5...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2007-01-15)
More Articles from AIDS Weekly
- HIV/AIDS Research
HIV treatments improve health, but nutritional issues remain - HIV/AIDS Therapy
Panacos announces first cohort results of Phase IIb study of bevirimat - HIV/AIDS
Findings from Institute of Microbiology and Epidemiology advance knowledge in HIV/AIDS - HIV/AIDS
New HIV/AIDS in children research has been reported by scientists at Johns Hopkins Medical Institutions, Division of General Pediatrics - HIV/AIDS Cancer Therapy
New findings from University of Wisconsin in the area of HIV/AIDS cancer therapy published - HIV/AIDS Co-Infection Genetics
Data on HIV/AIDS co-infection genetics published by researchers at Drexel University - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
